Cargando…

Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors (PNETs) are classified based on their histologic differentiation and proliferative indices, which have been used extensively to determine prognosis. Advances in next-generation sequencing and other high-throughput techniques have allowed researchers to objectively ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatani, Praveen Dilip, Agarwal, Sunita Kishore, Sadowski, Samira Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848028/ https://www.ncbi.nlm.nih.gov/pubmed/33537001 http://dx.doi.org/10.3389/fendo.2020.575620

Ejemplares similares

Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling
por: Li, Ning, et al.
Publicado: (2023)

Clinical Features, Management, and Molecular Characteristics of Familial Small Bowel Neuroendocrine Tumors
por: Lim, James Y., et al.
Publicado: (2021)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
por: Mei, Wentong, et al.
Publicado: (2023)

Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?
por: Jannin, Arnaud, et al.
Publicado: (2023)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
por: Colao, Annamaria, et al.
Publicado: (2020)

Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes
por: Cui, Yougang, et al.
Publicado: (2023)

Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
por: Crabtree, Judy S.
Publicado: (2017)

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer
por: Zhang, Biao, et al.
Publicado: (2023)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2021)

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice
por: van Beek, Dirk-Jan, et al.
Publicado: (2022)

Visual analytics identifies key miRNAs for differentiating peripancreatic paraganglioma and pancreatic neuroendocrine tumors
por: Enguita, Jose María, et al.
Publicado: (2023)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report
por: Mehta, Roopa, et al.
Publicado: (2020)

A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
por: Soczomski, Przemysław, et al.
Publicado: (2021)

Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients
por: Krogh, Sara, et al.
Publicado: (2022)

Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment
por: Luo, Shuaiwu, et al.
Publicado: (2023)

Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review
por: Chang, Shih-Chun, et al.
Publicado: (2021)

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
por: Zhang, Wu-Hu, et al.
Publicado: (2022)

Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study
por: Yang, Zhen, et al.
Publicado: (2022)

Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer
por: Podetta, Michele, et al.
Publicado: (2018)

Editorial: Neuroendocrine tumors: the road to precision medicine
por: La Salvia, Anna, et al.
Publicado: (2023)

Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study
por: Tan, Qingquan, et al.
Publicado: (2022)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

SUN-115 Distinct DNA Methylation Signature in Neuroendocrine Tumors of Different Primary Sites and Hereditary Predisposition
por: Tirosh, Amit, et al.
Publicado: (2020)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

Alternative Polyadenylation of Tumor Suppressor Genes in Small Intestinal Neuroendocrine Tumors
por: Rehfeld, Anders, et al.
Publicado: (2014)

Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors
por: Wen, Siqi, et al.
Publicado: (2021)

Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
por: Gil, Joan, et al.
Publicado: (2023)

Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumor
por: Song, Lili, et al.
Publicado: (2022)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report
por: Aversa, John G., et al.
Publicado: (2020)

Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center
por: Calissendorff, Jan, et al.
Publicado: (2021)

Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
por: Herring, Brendon, et al.
Publicado: (2021)

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
por: Vida Navas, Elena María, et al.
Publicado: (2021)

mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
por: Zanini, Sara, et al.
Publicado: (2020)

Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors
por: Wang, Xiao Bin, et al.
Publicado: (2022)

Nomogram for preoperative estimation of histologic grade in gastrointestinal neuroendocrine tumors
por: Wu, Zhi-Qi, et al.
Publicado: (2022)

The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
por: Harris, Philip E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_utkoltavovhaardboo2vqeacgj